CN117940109A - Composition for preventing bromhidrosis - Google Patents
Composition for preventing bromhidrosis Download PDFInfo
- Publication number
- CN117940109A CN117940109A CN202280062267.6A CN202280062267A CN117940109A CN 117940109 A CN117940109 A CN 117940109A CN 202280062267 A CN202280062267 A CN 202280062267A CN 117940109 A CN117940109 A CN 117940109A
- Authority
- CN
- China
- Prior art keywords
- composition
- bromhidrosis
- preventing
- acid
- inhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 246
- 208000035985 Body Odor Diseases 0.000 title claims abstract description 135
- 206010055000 Bromhidrosis Diseases 0.000 title claims abstract description 133
- 230000003405 preventing effect Effects 0.000 title claims abstract description 114
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims abstract description 138
- 239000000126 substance Substances 0.000 claims abstract description 87
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 68
- 150000003839 salts Chemical class 0.000 claims abstract description 22
- 150000003851 azoles Chemical class 0.000 claims abstract description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 45
- 238000004519 manufacturing process Methods 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 39
- -1 alum Chemical compound 0.000 claims description 36
- 239000003963 antioxidant agent Substances 0.000 claims description 36
- 230000003078 antioxidant effect Effects 0.000 claims description 36
- 235000006708 antioxidants Nutrition 0.000 claims description 36
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 24
- 238000001556 precipitation Methods 0.000 claims description 23
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims description 17
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 claims description 17
- 229960004125 ketoconazole Drugs 0.000 claims description 17
- 235000015165 citric acid Nutrition 0.000 claims description 15
- 229960004106 citric acid Drugs 0.000 claims description 15
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 claims description 15
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 14
- 239000006071 cream Substances 0.000 claims description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 13
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 12
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical group ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 claims description 12
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 12
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 12
- 239000004310 lactic acid Substances 0.000 claims description 12
- 235000014655 lactic acid Nutrition 0.000 claims description 12
- 229960000448 lactic acid Drugs 0.000 claims description 12
- 229960002509 miconazole Drugs 0.000 claims description 12
- 235000002906 tartaric acid Nutrition 0.000 claims description 12
- 239000011975 tartaric acid Substances 0.000 claims description 12
- 229960001367 tartaric acid Drugs 0.000 claims description 12
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 11
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 11
- 239000001263 FEMA 3042 Substances 0.000 claims description 11
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 11
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 11
- 229940037003 alum Drugs 0.000 claims description 11
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 claims description 11
- 239000001630 malic acid Substances 0.000 claims description 11
- 229940099690 malic acid Drugs 0.000 claims description 11
- 235000011090 malic acid Nutrition 0.000 claims description 11
- 239000000473 propyl gallate Substances 0.000 claims description 11
- 235000010388 propyl gallate Nutrition 0.000 claims description 11
- 229940075579 propyl gallate Drugs 0.000 claims description 11
- 235000015523 tannic acid Nutrition 0.000 claims description 11
- 229940033123 tannic acid Drugs 0.000 claims description 11
- 229920002258 tannic acid Polymers 0.000 claims description 11
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 11
- TYZFMFVWHZKYSE-UHFFFAOYSA-N 3-mercaptohexanol Chemical compound CCCC(S)CCO TYZFMFVWHZKYSE-UHFFFAOYSA-N 0.000 claims description 10
- 210000001099 axilla Anatomy 0.000 claims description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 9
- 229930003268 Vitamin C Natural products 0.000 claims description 9
- 239000011732 tocopherol Substances 0.000 claims description 9
- 235000010384 tocopherol Nutrition 0.000 claims description 9
- 229930003799 tocopherol Natural products 0.000 claims description 9
- 229960001295 tocopherol Drugs 0.000 claims description 9
- 235000019154 vitamin C Nutrition 0.000 claims description 9
- 239000011718 vitamin C Substances 0.000 claims description 9
- 229940045997 vitamin a Drugs 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 7
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 6
- 235000020778 linoleic acid Nutrition 0.000 claims description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 6
- NTWSIWWJPQHFTO-AATRIKPKSA-N (2E)-3-methylhex-2-enoic acid Chemical compound CCC\C(C)=C\C(O)=O NTWSIWWJPQHFTO-AATRIKPKSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 claims description 5
- RSFQOQOSOMBPEJ-UHFFFAOYSA-N 3-Methyl-2-hexenoic acid Natural products CCC(C)=CC(O)=O RSFQOQOSOMBPEJ-UHFFFAOYSA-N 0.000 claims description 5
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims description 5
- RGRNSTGIHROKJB-UHFFFAOYSA-N 3-hydroxy-3-methylhexanoic acid Chemical compound CCCC(C)(O)CC(O)=O RGRNSTGIHROKJB-UHFFFAOYSA-N 0.000 claims description 5
- PSALIMFZUGITJC-UHFFFAOYSA-N 3-methyl-3-sulfanylhexan-1-ol Chemical compound CCCC(C)(S)CCO PSALIMFZUGITJC-UHFFFAOYSA-N 0.000 claims description 5
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000012669 liquid formulation Substances 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 4
- 150000002916 oxazoles Chemical class 0.000 claims description 3
- 241001122767 Theaceae Species 0.000 claims 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- 230000000694 effects Effects 0.000 description 31
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 24
- 229960005040 miconazole nitrate Drugs 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 238000011156 evaluation Methods 0.000 description 15
- 238000009472 formulation Methods 0.000 description 11
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 10
- 229960004063 propylene glycol Drugs 0.000 description 10
- 235000013772 propylene glycol Nutrition 0.000 description 10
- 244000269722 Thea sinensis Species 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 8
- 235000013616 tea Nutrition 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- 230000001953 sensory effect Effects 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 238000013329 compounding Methods 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 5
- WOKDXPHSIQRTJF-UHFFFAOYSA-N 3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO WOKDXPHSIQRTJF-UHFFFAOYSA-N 0.000 description 5
- 239000003212 astringent agent Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 239000011787 zinc oxide Substances 0.000 description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- 239000003463 adsorbent Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 4
- 239000003429 antifungal agent Substances 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 229940041616 menthol Drugs 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 3
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 3
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 230000001166 anti-perspirative effect Effects 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002826 coolant Substances 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- 229940072106 hydroxystearate Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 3
- 229960004232 linoleic acid Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 229940108325 retinyl palmitate Drugs 0.000 description 3
- 235000019172 retinyl palmitate Nutrition 0.000 description 3
- 239000011769 retinyl palmitate Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 3
- AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 description 2
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 2
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 2
- QXHHHPZILQDDPS-UHFFFAOYSA-N 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound S1C=CC(COC(CN2C=NC=C2)C=2C(=CC(Cl)=CC=2)Cl)=C1Cl QXHHHPZILQDDPS-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical group NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- GHJWNRRCRIGGIO-UHFFFAOYSA-N Fosfluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(OP(O)(=O)O)CN1C=NC=N1 GHJWNRRCRIGGIO-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ZRTQSJFIDWNVJW-WYMLVPIESA-N Lanoconazole Chemical compound ClC1=CC=CC=C1C(CS\1)SC/1=C(\C#N)N1C=NC=C1 ZRTQSJFIDWNVJW-WYMLVPIESA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- 206010040904 Skin odour abnormal Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229940022663 acetate Drugs 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229940063656 aluminum chloride Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 229960002206 bifonazole Drugs 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229960004022 clotrimazole Drugs 0.000 description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960003913 econazole Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 229950008518 fosfluconazole Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229950010163 lanoconazole Drugs 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229960003483 oxiconazole Drugs 0.000 description 2
- QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960004838 phosphoric acid Drugs 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 229960002607 sulconazole Drugs 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 229960002722 terbinafine Drugs 0.000 description 2
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 2
- 229960004214 tioconazole Drugs 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 2
- 229960004740 voriconazole Drugs 0.000 description 2
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 description 2
- 229960001296 zinc oxide Drugs 0.000 description 2
- RIUORJCWAHCMSA-UHFFFAOYSA-L zinc;4-aminobenzenesulfonate Chemical group [Zn+2].NC1=CC=C(S([O-])(=O)=O)C=C1.NC1=CC=C(S([O-])(=O)=O)C=C1 RIUORJCWAHCMSA-UHFFFAOYSA-L 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- NRWMBHYHFFGEEC-KTKRTIGZSA-N (9Z)-1-O-octadec-9-enyl glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-KTKRTIGZSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- MPIPASJGOJYODL-SFHVURJKSA-N (R)-isoconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@@H](OCC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 MPIPASJGOJYODL-SFHVURJKSA-N 0.000 description 1
- VDVMOGXIBBDZNI-DLEQIPTRSA-N (Z)-octadec-9-enoic acid propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O VDVMOGXIBBDZNI-DLEQIPTRSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- GLXBPZNFNSLJBS-UHFFFAOYSA-N 11-methyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCC(C)C GLXBPZNFNSLJBS-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- WGKHLTQBAAWSSR-UHFFFAOYSA-N 16-methylheptadecyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCCCCCCCCCCCCCCCC(C)C WGKHLTQBAAWSSR-UHFFFAOYSA-N 0.000 description 1
- WPIOBXGJZUSKGK-UHFFFAOYSA-N 16-methylheptadecyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C WPIOBXGJZUSKGK-UHFFFAOYSA-N 0.000 description 1
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 1
- VRBHTEGUHVNKEA-UHFFFAOYSA-N 16-methylheptadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C VRBHTEGUHVNKEA-UHFFFAOYSA-N 0.000 description 1
- YUSLYKMVQSVFDX-UHFFFAOYSA-N 2,2,3,3,4-pentahydroxyoctadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)C(O)(O)C(O)(O)C(O)=O YUSLYKMVQSVFDX-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- PHDVPEOLXYBNJY-KTKRTIGZSA-N 2-(2-hydroxyethoxy)ethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOCCO PHDVPEOLXYBNJY-KTKRTIGZSA-N 0.000 description 1
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- WCAYFVDQSNFHOB-UHFFFAOYSA-N 2-hexyldecyl 2,2-dimethyloctanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)C(C)(C)CCCCCC WCAYFVDQSNFHOB-UHFFFAOYSA-N 0.000 description 1
- VDHIEQOYPSVNIM-UHFFFAOYSA-N 2-hexyldecyl 2-ethylhexanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)C(CC)CCCC VDHIEQOYPSVNIM-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QNJOVLAFLJQFBF-UHFFFAOYSA-N 2-octyldodecyl 16-methylheptadecanoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C QNJOVLAFLJQFBF-UHFFFAOYSA-N 0.000 description 1
- OYRKAUXRSTZVFT-UHFFFAOYSA-N 2-octyldodecyl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)C(C)(C)CCCCCC OYRKAUXRSTZVFT-UHFFFAOYSA-N 0.000 description 1
- PTPDZZWUOHQSLG-UHFFFAOYSA-N 2-octyldodecyl 2,2-dimethylpropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)(C)C)CCCCCCCC PTPDZZWUOHQSLG-UHFFFAOYSA-N 0.000 description 1
- ZIIVEKCKOPDBLT-UHFFFAOYSA-N 2-octyldodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)O)CCCCCCCC ZIIVEKCKOPDBLT-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- JAUFWPNLLLUYNV-UHFFFAOYSA-N 3-(16-methylheptadecoxy)propane-1,2-diol Chemical compound CC(C)CCCCCCCCCCCCCCCOCC(O)CO JAUFWPNLLLUYNV-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- HXKFHJZYKMZCOZ-YCBFMBTMSA-N C(CCCCCCCCCCC)OC([C@@H](N)CCC(=O)OCCCCCCCCCCCC)=O.[Na] Chemical compound C(CCCCCCCCCCC)OC([C@@H](N)CCC(=O)OCCCCCCCCCCCC)=O.[Na] HXKFHJZYKMZCOZ-YCBFMBTMSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- PRLUQOOFPFWUKQ-KKTNLPSRSA-N [(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] (z)-octadec-9-enoate Chemical compound C1C[C@@H]2[C@@]3(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C[C@@H]3CC[C@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@]21C PRLUQOOFPFWUKQ-KKTNLPSRSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- GORMSINSWZJIKL-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-dimethylpropyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC GORMSINSWZJIKL-UHFFFAOYSA-N 0.000 description 1
- PCUSEPQECKJFFS-UHFFFAOYSA-N [3-tetradecanoyloxy-2,2-bis(tetradecanoyloxymethyl)propyl] tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC PCUSEPQECKJFFS-UHFFFAOYSA-N 0.000 description 1
- CITHMWNQCVRPGG-UHFFFAOYSA-N [Na].[Na].[Na].NCCN Chemical compound [Na].[Na].[Na].NCCN CITHMWNQCVRPGG-UHFFFAOYSA-N 0.000 description 1
- ZFJFYUXFKXTXGT-UHFFFAOYSA-N [dimethyl(methylsilyloxy)silyl]oxy-[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilane Chemical compound C[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C ZFJFYUXFKXTXGT-UHFFFAOYSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- JGDITNMASUZKPW-UHFFFAOYSA-K aluminium trichloride hexahydrate Chemical compound O.O.O.O.O.O.Cl[Al](Cl)Cl JGDITNMASUZKPW-UHFFFAOYSA-K 0.000 description 1
- 229940009861 aluminum chloride hexahydrate Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- PKVYKIKWKPWIMO-UHFFFAOYSA-N bis(2-butyloctyl) decanedioate Chemical compound CCCCCCC(CCCC)COC(=O)CCCCCCCCC(=O)OCC(CCCC)CCCCCC PKVYKIKWKPWIMO-UHFFFAOYSA-N 0.000 description 1
- SAOKZLXYCUGLFA-UHFFFAOYSA-N bis(2-ethylhexyl) adipate Chemical compound CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940048851 cetyl ricinoleate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- BOUIEBMBWBCUPB-UHFFFAOYSA-N decyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCC BOUIEBMBWBCUPB-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- DMMXZLMYEUEJFT-UHFFFAOYSA-N ethyl 16-methylheptadecanoate Chemical compound CCOC(=O)CCCCCCCCCCCCCCC(C)C DMMXZLMYEUEJFT-UHFFFAOYSA-N 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- FPMPNVIMFPEKRN-UHFFFAOYSA-N hexyl 16-methylheptadecanoate Chemical compound CCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C FPMPNVIMFPEKRN-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940031576 hydroxypropylbetadex (0.58-0.68 ms) Drugs 0.000 description 1
- 229960004849 isoconazole Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229940113915 isostearyl palmitate Drugs 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940093932 potassium hydroxide Drugs 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- TXGSOSAONMOPDL-UHFFFAOYSA-N propan-2-yl 3,4,5-trihydroxybenzoate Chemical compound CC(C)OC(=O)C1=CC(O)=C(O)C(O)=C1 TXGSOSAONMOPDL-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 229940010310 propylene glycol dioleate Drugs 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940083608 sodium hydroxide Drugs 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a composition for preventing bromhidrosis and a composition for inhibiting the generation of malodor substances. The composition for preventing bromhidrosis contains at least 1 azole component selected from the group consisting of azoles and salts thereof, wherein the azole component content is 0.01 to 0.2 mass% based on the bromhidrosis preventing composition. A composition for inhibiting the generation of an odorous substance, which comprises at least 1 kind of azole component selected from the group consisting of azoles and salts thereof, wherein the amount of the azole component is 0.01 to 0.2% by mass based on the odorous substance generation inhibiting composition.
Description
Technical Field
The present invention relates to an underarm odor preventing composition and an odor substance production inhibiting composition. More specifically, the present invention relates to an anti-bromhidrosis composition and an odor substance generation-inhibiting composition containing at least 1 azole component selected from the group consisting of azoles and salts thereof.
Background
In recent years, unpleasant feeling given to the surroundings by body odor has become a problem, and among body odor, particularly, people who mind bromhidrosis have increased. Therefore, various antiperspirants and deodorants have been marketed. In addition, an anti-bromhidrosis agent and an anti-bromhidrosis method have been developed, and patent document 1 proposes a method for preventing the generation of malodor in the armpit of a person, comprising: a bactericidal composition containing oxazole and the like is applied to the armpit.
On the other hand, patent document 2 discloses a solution for the treatment of tinea pedis, which contains terbinafine as an antifungal agent, aluminum chloride hexahydrate as an antiperspirant, and ethanol as a solvent carrier.
Prior art literature
Patent literature
Patent document 1: U.S. patent application publication No. 2003/0161799 specification
Patent document 2: japanese patent application laid-open No. 2019-526631
Disclosure of Invention
Problems to be solved by the invention
Patent document 1 does not specifically disclose the content of oxazole and the like in the bactericidal composition.
Further, document 2 is cited for the purpose of providing a composition effective for treating tinea pedis by using an antifungal agent in combination with an antiperspirant, and no means for preventing bromhidrosis or inhibiting the generation of malodor substances has been proposed. Further, the concentration of terbinafine in the above-described solution for the treatment of tinea pedis disclosed in patent document 2 is about 1%.
The purpose of the present invention is to provide a composition for preventing bromhidrosis and a composition for inhibiting the production of an odor substance.
Means for solving the problems
As a result of intensive studies to solve the above problems, the present inventors have found that underarm odor can be prevented by a small amount of an azole component, and have completed the present invention.
Further, the present inventors have found that the generation of an odor substance can be suppressed by a small amount of an azole component, and completed the present invention.
Namely, the invention relates to
[1] A composition for preventing bromhidrosis, which comprises at least 1 azole component selected from the group consisting of azoles and its salts,
The azole component is contained in an amount of 0.01 to 0.2 mass% based on the composition for preventing bromhidrosis,
[2] The composition for preventing bromhidrosis according to [1], wherein the azole is miconazole or ketoconazole,
[3] The composition for preventing bromhidrosis according to [1] or [2], which further comprises an astringent,
[4] The composition for preventing bromhidrosis according to [3], wherein the astringent is at least 1 astringent selected from the group consisting of zinc p-phenolsulfonate, aluminum chlorohydrate, citric acid, lactic acid, tannic acid, alum, succinic acid, tartaric acid and malic acid,
[5] The composition for preventing bromhidrosis according to [3], wherein the precipitation of the azole component is suppressed,
[6] The composition for preventing bromhidrosis according to [1] or [2], which further comprises an antioxidant,
[7] The composition for preventing bromhidrosis according to [6], wherein the antioxidant is at least 1 antioxidant selected from the group consisting of tocopherol and derivatives thereof, tea extract, vitamin A and derivatives thereof, vitamin C and derivatives thereof, propyl gallate and linoleic acid,
[8] The composition for preventing bromhidrosis according to [6], wherein the precipitation of the azole component is suppressed,
[9] The composition for preventing bromhidrosis according to [1] or [2], wherein the form of the composition for preventing bromhidrosis is a form selected from the group consisting of cream, liquid, spray, stick and roll-on,
[10] A method for preventing bromhidrosis, which comprises applying the bromhidrosis preventing composition according to [1] or [2] to the axilla.
Furthermore, the invention relates to
[11] A composition for inhibiting the generation of an odorous substance, which comprises at least 1 azole component selected from the group consisting of azoles and salts thereof,
The azole component content is 0.01 to 0.2 mass% based on the composition for inhibiting the generation of malodorous substances,
[12] The composition for inhibiting the production of an odorous substance according to [11], wherein the azole is miconazole or ketoconazole,
[13] The composition for inhibiting the production of an odorant according to [11] or [12], wherein the odorant is at least 1 odorant selected from the group consisting of 3-hydroxy-3-methylhexanoic acid, 3-methyl-2-hexenoic acid, isovaleric acid, 3-methyl-3-mercaptohexane-1-ol and 3-mercapto-1-hexanol,
[14] The composition for inhibiting the production of an odorous substance as described in [11] or [12], which further comprises an astringent,
[15] The composition for inhibiting the production of an malodorous substance according to [14], wherein the astringent is at least 1 astringent selected from the group consisting of zinc p-phenolsulfonate, aluminum chlorohydrate, citric acid, lactic acid, tannic acid, alum, succinic acid, tartaric acid and malic acid,
[16] The composition for inhibiting the production of an odorous substance according to [14], wherein the precipitation of the azole component is inhibited,
[17] The composition for inhibiting the production of an odorous substance as described in [11] or [12], which further comprises an antioxidant,
[18] The composition for inhibiting the production of an odorous substance according to [17], wherein the antioxidant is at least 1 antioxidant selected from the group consisting of tocopherol and derivatives thereof, tea extract, vitamin A and derivatives thereof, vitamin C and derivatives thereof, propyl gallate and linoleic acid,
[19] The composition for inhibiting the production of an odorous substance according to [17], wherein the precipitation of the azole component is inhibited,
[20] The composition for suppressing the production of an odorous substance as described in [11] or [12], wherein the composition for suppressing the production of an odorous substance is in a form selected from the group consisting of cream, liquid, spray, stick and roll-on,
[21] A method of suppressing the production of an odorous substance, which comprises applying the odorous substance production-suppressing composition of [11] or [12] to the axilla.
Further, the present invention relates to
[22] A method of inhibiting precipitation of an azole component comprising: at least 1 selected from zinc p-phenolsulfonate, aluminum chlorohydrate, citric acid, lactic acid, tannic acid, alum, succinic acid, tartaric acid and malic acid are mixed in a composition for external use containing at least 1 selected from the group consisting of oxazoles and salts thereof,
[23] A method of inhibiting precipitation of an azole component comprising: at least 1 selected from tocopherol and its derivatives, tea extract, vitamin A and its derivatives, vitamin C and its derivatives, propyl gallate and linoleic acid are mixed with a topical composition containing at least 1 selected from oxazole and its salts,
[24] The method according to [22] or [23], wherein the azole is miconazole or ketoconazole,
[25] The method according to [22] or [23], wherein the external composition is in the form of a liquid,
[26] The method according to [22] or [23], wherein the composition for external use is at least 1 selected from the group consisting of an composition for preventing bromhidrosis and a composition for suppressing the generation of an odorous substance,
[27] The composition for preventing bromhidrosis according to [1], wherein at least 1 azole component selected from the group consisting of azoles and salts thereof is miconazole nitrate.
ADVANTAGEOUS EFFECTS OF INVENTION
The composition for preventing bromhidrosis of the present invention has an effect of preventing bromhidrosis.
The composition for preventing bromhidrosis of the present invention has an effect of being able to be stored stably by containing a specific astringent or a specific antioxidant.
The composition for suppressing the generation of an odorous substance of the present invention has an effect of suppressing the generation of an odorous substance.
The composition for suppressing the generation of an odorous substance of the present invention has an effect of being able to be stably stored by containing a specific astringent or a specific antioxidant.
In addition, the present invention has an effect that precipitation of an azole component during storage is suppressed by making the content of the azole component contained in the composition small.
Drawings
Fig. 1 is a graph showing the results of human sensory evaluation tests concerning the effect of preventing bromhidrosis, using the composition of example 1 and the composition of comparative example 1 in test example 1.
Fig. 2 is a graph showing the results of human sensory evaluation tests concerning the effect of preventing bromhidrosis, using the composition of example 2 and the composition of comparative example 1 in test example 1.
Fig. 3 is a graph showing the results of human sensory evaluation tests concerning the effect of preventing bromhidrosis, using the composition of example 3 and the composition of comparative example 1 in test example 1.
Fig. 4 is a graph showing the results of human sensory evaluation tests concerning the effect of preventing bromhidrosis in test example 1 using the composition of example 4 and the composition of comparative example 2.
Fig. 5 is a graph showing the results of human sensory evaluation tests concerning the effect of preventing bromhidrosis in test example 1 using the composition of example 5 and the composition of comparative example 2.
FIG. 6 is a graph showing the effect of inhibiting the production of 3-hydroxy-3-methylhexanoic acid in test example 2.
FIG. 7 is a graph showing the effect of inhibiting the production of 3-methyl-2-hexenoic acid in test example 2.
FIG. 8 is a graph showing the inhibitory effect on the production of isovaleric acid in test example 2.
FIG. 9 is a graph showing the production inhibitory effect of 3-methyl-3-mercaptohexane-1-ol in test example 2.
FIG. 10 is a graph showing the effect of inhibiting the production of 3-mercapto-1-hexanol in test example 2.
Detailed Description
[ Composition for preventing bromhidrosis ]
The present invention relates to a composition for preventing bromhidrosis, which comprises at least 1 azole component selected from the group consisting of azoles and salts thereof, wherein the azole component content is 0.01 to 0.2% by mass based on the bromhidrosis preventing composition.
The composition for preventing bromhidrosis of the present invention is used for bromhidrosis, but may be used for malodor in other parts (scalp, face, trunk, crotch, sole, etc.).
< Azole component >)
In the present invention, the azole component plays a role in preventing bromhidrosis, and is at least 1 selected from the group consisting of azole and salts thereof.
The azole component that can be used in the present invention is not particularly limited, and examples thereof include miconazole, clotrimazole, econazole, tioconazole, oxiconazole, fluconazole, itraconazole, ketoconazole, chloroconazole, noconazole, isoconazole, sulconazole, bifonazole, voriconazole, fosfluconazole, lanoconazole, chloriconazole, and salts thereof, and examples thereof include nitrate salts and hydrochloride salts.
The azole component may be used alone in an amount of 1 kind, but may be used in an amount of 2 or more kinds.
The azole component is preferably miconazole, clotrimazole, econazole, tioconazole, oxiconazole, ketoconazole, sulconazole, bifonazole, voriconazole, fosfluconazole, lanoconazole, chloriconazole or a salt thereof, more preferably miconazole, ketoconazole or a salt thereof with practical results, which is used as a drug for external use or a quasi drug, further preferably miconazole or a salt thereof, particularly preferably miconazole nitrate.
In addition, as another embodiment, ketoconazole is particularly preferable as the azole component.
Since the present invention can exhibit such an effect that the bromhidrosis can be prevented by a small amount, specifically, an azole component of 0.2 mass% or less based on the total mass of the bromhidrosis-preventing composition, the content of the azole component is 0.01 to 0.2 mass%, preferably 0.01 to 0.1 mass%, more preferably 0.03 to 0.1 mass%, and even more preferably 0.04 to 0.06 mass% based on the total mass of the bromhidrosis-preventing composition.
Astringents >
The composition for preventing bromhidrosis of the present invention may contain an astringent.
By containing the astringent, the effect of preventing bromhidrosis can be improved. In addition, the precipitation of the azole component from the composition for preventing bromhidrosis can be suppressed, and the composition for preventing bromhidrosis can be stably stored. Further, the astringent can exert a astringent effect depending on the content thereof.
Examples of astringents include zinc p-phenolsulfonate, zinc sulfate, zinc oxide and other zinc salts, aluminum chlorohydrate, allantoin aluminum chlorohydrate and other aluminum salts, alum and other metal salts, citric acid, lactic acid, tannic acid, succinic acid, malic acid, tartaric acid and other organic acids. The astringent may be used singly or in combination of 1 or 2 or more.
In the present invention, as the astringent, at least 1 selected from zinc p-phenolsulfonate, aluminum chlorohydrate, citric acid, lactic acid, tannic acid, alum, succinic acid, tartaric acid and phosphoric acid is preferable, and at least 1 selected from zinc p-phenolsulfonate and aluminum chlorohydrate is more preferable.
In the present invention, the amount of the astringent is not particularly limited as long as it is a sufficient amount to improve the effect of preventing bromhidrosis and to stably store the bromhidrosis-preventing composition, and is preferably 0.01 to 15% by mass, more preferably 0.1 to 10% by mass, and even more preferably 0.1 to 5% by mass, based on the total mass of the bromhidrosis-preventing composition.
In the present invention, the content ratio of the azole component to the astringent is preferably 1:1 to 1000, more preferably 1:1 to 300, still more preferably 1:1 to 20, particularly preferably 1:1 to 10, in terms of mass ratio.
In the case where the astringent is zinc sulfanilate, the content ratio of the azole component to zinc sulfanilate is preferably 1:1 to 1000, more preferably 1:1 to 300, and even more preferably 1:1 to 50 in terms of mass ratio.
When the astringent is aluminum chlorohydrate, the azole component is preferably contained in a proportion of 1:1 to 1000, more preferably 1:1 to 300, and even more preferably 1:1 to 200, by mass.
< Antioxidant >
The composition for preventing bromhidrosis of the present invention may contain an antioxidant.
By containing the antioxidant, the precipitation of the azole component from the composition for preventing bromhidrosis can be suppressed, and the composition for preventing bromhidrosis can be stably stored. In addition, the antioxidant can exert an antioxidant effect according to its content.
The antioxidant may be contained without particular limitation as long as it is a substance confirming safety to the human body, and for example, sodium metabisulfite, dibutyl hydroxy toluene (BHT), butyl Hydroxy Anisole (BHA), propyl gallate, isopropyl gallate, tocopherol and its derivatives (for example, tocopherol acetate, sodium tocopheryl phosphate and the like), tea extract (for example, extract obtained by extracting green tea with water, ethanol solution, propylene glycol solution or glycerin solution and the like), vitamin a and its derivatives (for example, retinoic acid, retinol palmitate and the like), vitamin C and its derivatives (for example, ascorbic acid 2-glucoside, 3-O-ethyl ascorbic acid and the like), ferulic acid, linoleic acid, hydroquinone, astaxanthin, nicotinamide, γ -oryzanol, natural vitamin E, placenta extract and the like can be used. The antioxidant may be used singly or in an amount of 1 or 2 or more.
In the present invention, the antioxidant is preferably at least 1 selected from tocopherol and its derivatives, tea extract, vitamin a and its derivatives, vitamin C and its derivatives, propyl gallate and linoleic acid.
In the present invention, the content of the antioxidant is not particularly limited as long as it is sufficient to improve the effect of preventing bromhidrosis and to stably store the bromhidrosis-preventing composition, and is preferably 0.01 to 15% by mass, more preferably 0.05 to 10% by mass, and even more preferably 0.05 to 5% by mass, based on the total mass of the bromhidrosis-preventing composition.
In the present invention, the content ratio of the azole component to the antioxidant is preferably 1:1 to 1000, more preferably 1:1 to 300, still more preferably 1:1 to 20, particularly preferably 1:1 to 10, in terms of mass ratio.
< Other additives >)
The composition for preventing bromhidrosis of the present invention may contain, in addition to the above-mentioned components, at least 1 or more oily base, moisturizer, surfactant, alcohol, cooling agent, perfume, anti-inflammatory agent, ultraviolet absorber, antibacterial/antiseptic agent, thickener, chelating agent, pH regulator, solubilizer, cosolvent, stabilizer, pigment, powder (e.g., hydroxyapatite, etc.), adsorbent (e.g., hydroxypropyl-. Beta. -cyclodextrin, etc.), film-forming agent (e.g., (acrylate/polydimethylsiloxane) copolymer, acrylate copolymer, etc.), and the like, within a range that does not impair the object of the present invention.
As the base material of the oil-based material, examples thereof include isopropyl myristate, butyl myristate, isopropyl palmitate, butyl stearate, ethyl oleate, ethyl linoleate, isopropyl linoleate, cetyl octanoate, hexyl laurate, decyl myristate, myristyl myristate, cetyl palmitate, stearyl stearate, decyl oleate, oleyl oleate, cetyl ricinoleate, isostearyl laurate, isotridecyl myristate, 2-hexyldecyl myristate, isostearyl myristate, 2-octyldodecyl myristate, 2-ethylhexyl palmitate, 2-hexyldecyl palmitate, isostearyl palmitate, 2-ethylhexyl stearate, 2-hexyldecyl stearate, isodecyl oleate, 2-octyldodecyl ricinoleate, ethyl isostearate, isopropyl isostearate, cetyl 2-ethylhexanoate, cetostearyl 2-ethylhexanoate, hexyl isostearate, ethylene glycol di-2-ethylhexanoate, ethylene glycol dioleate, propylene glycol dioctanoate, propylene glycol di (caprylate/caprate), propylene glycol dicaprate, propylene glycol dioleate, neopentyl glycol dicaprate, neopentyl glycol di-2-ethylhexanoate, glyceryl tricaprylate, glyceryl tri-2-ethylhexanoate, glyceryl tri (caprylate/caprate), glyceryl tri (undecanoate), glyceryl triisopalmitate, glyceryl triisostearate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, pentaerythritol tetra-2-ethylhexanoate, pentaerythritol tetramyristate, pentaerythritol tetraisostearate, dipentaerythritol fatty acid ester (1), 2-octyldodecyl pivalate, 2-hexyldecyl 2-ethylhexanoate, isostearyl 2-ethylhexanoate, 2-hexyldecyl dimethyloctanoate, 2-octyldodecyl dimethyloctanoate, 2-ethylhexyl isopalmitate, 2-hexyldecyl isostearate, isostearyl isostearate, 2-octyldodecyl isostearate, lauryl lactate, myristyl lactate, cetyl lactate, 2-octyldodecyl lactate, triethyl citrate acetyltriethyl citrate, acetyltributyl citrate, tri-2-ethylhexyl citrate, triisocetyl citrate, tri-2-octyldodecyl citrate, diisostearyl malate, 2-ethylhexyl hydroxystearate, di-2-ethylhexyl succinate, diisopropyl adipate, diisobutyl adipate, di-2-ethylhexyl adipate, diethyl sebacate, diisopropyl sebacate, di-2-ethylhexyl sebacate, dibutyl octyl sebacate, cholesteryl stearate, cholesteryl isostearate, cholesteryl hydroxystearate, cholesteryl oleate, dihydrocholesteryl oleate, phytosterol isostearate, phytosterol oleate, isocetyl 12-stearoyl hydroxystearate, ester oils such as stearyl 12-stearoyl hydroxystearate, isostearyl 12-stearoyl hydroxystearate, polyoxyethylene (3) acetate, cetyl ether of propylene oxide, and polyoxyethylene (3) acetate, isocetylether of propylene oxide; vegetable fats and oils such as avocado oil, castor oil, hardened castor oil, olive oil, cocoa butter, camellia oil, coconut oil, wood wax, jojoba oil, and grape seed oil; hydrocarbons such as squalane, liquid paraffin, microcrystalline wax, ceresin, paraffin, and petrolatum; higher alcohols such as cetyl alcohol, stearyl alcohol, hexyldecanol, octyldodecanol, etc.; and silicones such as methylpolysiloxane, decamethylpentasiloxane and methylpolysiloxane. The oil base may be used singly or in combination of 1 or 2 or more.
In the case where the composition for preventing bromhidrosis of the present invention contains an oily base, the content of the oily base is not particularly limited as long as the effect is confirmed. The content suitable for the formulation varies, for example, with respect to the cream, and is preferably 5 to 40% by mass, more preferably 10 to 30% by mass, based on the total mass of the composition for preventing bromhidrosis.
Examples of the humectant include chondroitin sulfate, sodium chondroitin sulfate, hyaluronic acid, sodium hyaluronate, collagen, glycerin, concentrated glycerin, dipropylene glycol, propylene glycol, 1, 3-butanediol, polyethylene glycol, polyoxyethylene methyl glucoside, xylitol, sorbitol, maltitol, urea, sodium pyrrolidone carboxylate, ceramide, trimethylglycine, a plant extract, and sodium dilauryl glutamate. The humectant may be used singly in an amount of 1 or 2 or more.
In the case where the composition for preventing bromhidrosis of the present invention contains a humectant, the content of the humectant is not particularly limited as long as the content is within a range in which the effect is confirmed. For example, the total mass of the composition for preventing bromhidrosis is preferably 0.1 to 70% by mass, more preferably 1 to 50% by mass.
Examples of the surfactant include nonionic surfactants such as diglycerol monooleate, diglycerol monoisostearate, hexaglycerol pentaoleate, hexaglycerol polyricinoleate, decaglycerol pentahydroxystearate, decaglycerol pentaisostearate, decaglycerol pentaoleate, decaglycerol heptaoleate, decaglycerol polyricinoleate, monooleyl glyceryl ether, isostearyl glyceryl ether, polyoxyethylene hardened castor oil, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbitol fatty acid ester, polyglyceryl fatty acid ester, polyoxyethylene glycerol fatty acid ester, polyoxyethylene sterols, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyethylene glycol fatty acid ester, polyoxyethylene isostearate and polyoxyethylene glycerol triisostearate. The surfactant may be used singly or in an amount of 1 or 2 or more.
In the case where the composition for preventing bromhidrosis of the present invention contains a surfactant, the content of the surfactant is not particularly limited as long as the effect is confirmed. For example, the total mass of the composition for preventing bromhidrosis is preferably 0.1 to 30% by mass, more preferably 0.5 to 15% by mass.
Examples of the alcohol include lower alcohols such as ethanol, propanol, isopropanol, butanol, pentanol and hexanol, and polyhydric alcohols such as butanediol, propylene glycol (1, 2-propanediol, 1, 3-propanediol), pentanediol, hexanediol and octanediol. The alcohol may be used singly or in an amount of 1 or 2 or more.
When the composition for preventing bromhidrosis of the present invention contains an alcohol, the content of the alcohol is not particularly limited, but is preferably 1 to 80% by mass, more preferably 1 to 60% by mass, based on the total mass of the composition for preventing bromhidrosis, for example.
Examples of the cooling agent include menthol, menthyl glyceryl ether, menthyl lactate, peppermint oil, camphor, and methyl salicylate. The cooling agent may be used singly or in an amount of 1 or 2 or more.
Examples of the perfume include natural perfumes such as citral, borneol and eugenol, synthetic perfumes such as anethole, benzyl benzoate and benzyl acetate, and blended perfumes. The perfume may be used singly in 1 kind or 2 kinds or more.
Examples of the anti-inflammatory agent include salicylic acid, isopropyl methylphenol, allantoin, dipotassium glycyrrhizinate, zinc oxide, tocopheryl acetate, menthol, and the like. The anti-inflammatory agent may be used singly in an amount of 1 or 2 or more.
Examples of the ultraviolet absorber include salicylic acid-based ultraviolet absorbers, cinnamic acid-based ultraviolet absorbers, benzoylmethane-based ultraviolet absorbers, and benzoate derivative ultraviolet absorbers. The ultraviolet absorber may be used singly or in an amount of 1 or 2 or more.
Examples of the antibacterial/antiseptic agent include methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, butyl parahydroxybenzoate, isopropyl parahydroxybenzoate, phenoxyethanol, benzoic acid, chlorhexidine gluconate, and the like. The antibacterial/antiseptic agent may be used singly 1 kind, or 2 kinds or more.
Examples of the thickener include alginic acid, carboxyvinyl polymer, guar gum, xanthan gum, methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, carboxymethyl cellulose, hydrophobic hydroxypropylmethyl cellulose, polyvinyl alcohol, bentonite, alkyl methacrylate copolymer, and (hydroxyethyl acrylate/Na acryloyldimethyl taurate) copolymer. The thickener may be used singly in an amount of 1 or 2 or more.
Examples of the chelating agent include ethylenediamine tetraacetate [ EDTA.2Na (disodium ethylenediamine tetraacetate), EDTA.3Na (trisodium ethylenediamine tetraacetate), EDTA.4Na (tetrasodium ethylenediamine tetraacetate) ], hydroxyethylphosphoric acid (hydroxyethyldiphosphonic acid), and trisodium ethylenediamine hydroxyethyl triacetate. The chelating agent may be used singly in an amount of 1 or 2 or more.
Examples of the pH adjuster include citric acid, sodium citrate, citric anhydride, succinic acid, sodium succinate, disodium succinate, phosphoric acid, sodium dihydrogen phosphate, anhydrous disodium hydrogen phosphate, lactic acid, sodium lactate, sodium hydroxide, and potassium hydroxide. The pH adjustor may be used singly in an amount of 1 or 2 or more.
The composition for preventing bromhidrosis of the present invention may contain water such as purified water and deionized water in addition to the above-mentioned components.
When the composition for preventing bromhidrosis of the present invention contains water, the content thereof is the remainder obtained by subtracting the total amount of the above components from the total amount (100 mass%) of the composition for preventing bromhidrosis.
The water content in the composition for preventing bromhidrosis of the present invention is not particularly limited, and examples thereof include 35 to 99 mass%, preferably 40 to 99 mass%, and more preferably 45 to 99 mass% based on the total mass of the composition for preventing bromhidrosis.
< Modulation method >
The method for preparing the composition for preventing bromhidrosis of the present invention is not particularly limited, and examples thereof include a method in which an azole component is mixed with any component and water as needed, and if needed, the mixture is subjected to a treatment such as heating or stirring to dissolve the components; or a method in which a solution in which an azole component is dispersed or dissolved, a solution in which an optional component is dispersed or dissolved, and the like are prepared separately, and these solutions are mixed, and if necessary, the mixture is subjected to a treatment such as heating or stirring, to dissolve the components.
The obtained composition for preventing bromhidrosis may be adjusted to a desired pH by adding the above-mentioned pH adjustor as needed.
The pH of the composition for preventing bromhidrosis of the present invention is not particularly limited, but is preferably 3 or more, more preferably 4 to 8, and still more preferably 4.5 to 7.
< Preparation form >)
Examples of the dosage form of the composition for preventing bromhidrosis of the present invention include creams, liquids, emulsions, lotions, gels, sticks, roll-ons, sprays, patches, and wiping tablets for impregnating sheets such as nonwoven fabrics with the composition for preventing bromhidrosis.
In addition, when the formulation is in an emulsified state such as cream or emulsion, the formulation may be either water-in-oil (W/O type) or oil-in-water (O/W type), and from the viewpoint of particularly good feel in use, water-in-oil (W/O type) is preferable.
In the present invention, from the viewpoint of applying/spraying the composition for preventing bromhidrosis and the like so as to be in sufficient contact with the bromhidrosis, the form of the composition for preventing bromhidrosis is preferably a cream, a liquid, a spray, a stick, or a ball, and more preferably a water-in-oil (W/O) type cream or liquid.
When the composition for preventing bromhidrosis of the present invention is formulated into a cream, the amount of the composition is usually 0.05 to 1 g/armpit, preferably 0.1 to 0.7 g/armpit.
When the composition for preventing bromhidrosis of the present invention is formulated into a liquid formulation, the coating amount thereof is usually 0.05 to 1 g/armpit, preferably 0.1 to 0.7 g/armpit.
When the composition for preventing bromhidrosis of the present invention is formulated into a spray, the amount of the composition is usually 0.05 to 1 g/armpit, preferably 0.1 to 0.7 g/armpit.
When the composition for preventing bromhidrosis of the present invention is formulated into a stick, the amount of the composition is usually 0.05 to 1 g/armpit, preferably 0.1 to 0.7 g/armpit.
When the composition for preventing bromhidrosis of the present invention is formulated into a ball preparation, the coating amount thereof is usually 0.05 to 1 g/armpit, preferably 0.1 to 0.7 g/armpit.
[ Method for preventing bromhidrosis ]
The present invention relates to a method for preventing bromhidrosis by applying the above composition for preventing bromhidrosis to the axilla.
As a method of applying the composition for preventing bromhidrosis to the axilla, there is a method of bringing the composition for preventing bromhidrosis into direct contact with the axilla by coating, spraying, or the like; and a method in which the composition for preventing bromhidrosis is brought into indirect contact with the armpit, using a sheet or the like impregnated with the composition for preventing bromhidrosis.
[ Composition for inhibiting malodor-generating substances ]
The present invention relates to a composition for inhibiting the generation of an odorous substance, which contains at least 1 kind of azole component selected from the group consisting of azoles and salts thereof, wherein the content of the azole component is 0.01 to 0.2% by mass based on the composition for inhibiting the generation of an odorous substance.
< Azole component >)
In the present invention, the azole component plays a role in suppressing the generation of malodorous substances.
The azole component contained in the composition for inhibiting the production of an malodor substance of the present invention may be the azole component described in the composition for preventing bromhidrosis.
< Odor substance >)
The malodor-imparting substance is not particularly limited, but at least 1 malodor-imparting substance selected from the group consisting of 3-hydroxy-3-methylhexanoic acid, 3-methyl-2-hexenoic acid, isovaleric acid, 3-methyl-3-mercaptohexane-1-ol and 3-mercapto-1-hexanol is preferable.
Astringents >
The composition for inhibiting the production of an malodor substance of the present invention may contain an astringent.
By containing the astringent, the effect of suppressing the generation of the odor substance can be improved. In addition, the deposition of the azole component from the composition for inhibiting the production of an odorous substance can be suppressed, and the composition for inhibiting the production of an odorous substance can be stably stored. Further, the astringent can exert a astringent effect depending on the content thereof.
As the astringent contained in the composition for inhibiting the generation of malodor substance of the present invention, the astringents described in the composition for preventing bromhidrosis can be used.
< Antioxidant >
The composition for inhibiting the production of an odorous substance of the present invention may contain an antioxidant.
By containing the antioxidant, the deposition of the azole component from the composition for suppressing the generation of an odorous substance can be suppressed, and the composition for suppressing the generation of an odorous substance can be stably stored. In addition, the antioxidant can exert an antioxidant effect according to its content.
As the antioxidant contained in the composition for inhibiting the production of an malodor substance of the present invention, the antioxidants described in the composition for preventing bromhidrosis can be used.
The composition for inhibiting the production of an malodor substance of the present invention may contain, in addition to the above-mentioned components, other additives and water described in the composition for preventing an underarm odor, within a range that does not impair the object of the present invention.
The method and the formulation of the composition for inhibiting the production of an malodor substance according to the present invention are as described in the composition for preventing bromhidrosis.
[ Method of suppressing the production of malodorous substances ]
The present invention relates to a method for suppressing the generation of an odorous substance by applying the composition for suppressing the generation of an odorous substance to the axilla.
As a method of applying the composition for suppressing the generation of an odor substance to the axilla, there is a method of bringing the composition for suppressing the generation of an odor substance into direct contact with the axilla by coating, spraying or the like; a method in which the odor substance generation-inhibiting composition is brought into indirect contact with the armpits, using a sheet or the like impregnated with the odor substance generation-inhibiting composition.
[ Method of inhibiting the precipitation of azole component ]
The invention relates to a method for inhibiting precipitation of an azole component, which comprises the following steps: at least 1 selected from zinc p-phenolsulfonate, aluminum chlorohydrate, citric acid, lactic acid, tannic acid, alum, succinic acid, tartaric acid and malic acid is mixed with a composition for external use containing at least 1 selected from the group consisting of oxazoles and salts thereof.
The present invention also relates to a method for inhibiting precipitation of an azole component, comprising: at least 1 selected from tocopherol and its derivatives, tea extract, vitamin A and its derivatives, vitamin C and its derivatives, propyl gallate and linoleic acid are mixed with a topical composition containing at least 1 selected from oxazole and its salts.
The dosage form of the external composition is not particularly limited, but is preferably a liquid formulation.
The composition for external use is not particularly limited, but is preferably at least 1 selected from the group consisting of an anti-bromhidrosis composition and an odor-substance generation-suppressing composition.
As various components that can be used as the azole component, the astringent, and the antioxidant used in the inhibition method of the present invention, the azole component, the astringent, and the antioxidant described in the composition for preventing bromhidrosis can be used.
The method of mixing the various components that can be used as an astringent or an antioxidant in the external composition is not particularly limited, and examples thereof include a method of directly mixing the various components in the external composition, a method of mixing a solution in which the various components are dissolved or dispersed in the external composition, and the like.
Examples
The present invention will be described more specifically with reference to the following examples, but the present invention is not limited to the examples.
Test example 1: evaluation of the effect of miconazole nitrate on preventing bromhidrosis
Compositions for preventing bromhidrosis (compositions for inhibiting malodor generation) of examples 1 to 3 (creams), examples 4 and 5 (solutions) and comparative examples 1 (creams) and 2 (solutions) were prepared according to the compositions shown in table 1 by a conventional method, and were subjected to a sensory evaluation test for evaluating the effect of preventing bromhidrosis.
Based on the odor evaluation criteria shown in table 2, 30 healthy adults with an average value of 4 to 7 of the odor of the armpit before application of the above composition for preventing bromhidrosis (composition for inhibiting the generation of an odorous substance) were extracted, and a double-blind comparison test was performed with comparative example 1 or 2 as a control. That is, the composition of example 1,2, 3, 4, or 5 was applied to one armpit of the subject, and the composition of comparative example 1 or 2 was applied to the other armpit at random, for a total of 4 days, 2 times a day and 1 time a day, with about 0.5g applied to each 1 time. The use of other anti-bromhidrosis agents and body washes containing bactericidal components was inhibited for 10 days before the start of the test. Furthermore, although the use of a shower was allowed in the test, the cleaning of the armpit was performed under supervision of the clinical facility, and was also prohibited until evaluation after 48 hours from the final coating. After 24 hours and 48 hours from the final application, 4 odor judges judged the odor of the armpit according to the odor evaluation criteria shown in table 2 below, and the average value was used. The results are shown in table 3 and fig. 1 to 5.
TABLE 1
TABLE 1
In the table, the amounts of the respective components represent mass% based on the total mass of the composition for preventing bromhidrosis (composition for inhibiting the production of malodor substance).
TABLE 2
Table 2 odor evaluation criteria
0 | No malodor at all |
1 | Threshold malodor |
2 | Very slight malodor |
3 | Slight malodor |
4 | Mild to moderate malodor |
5 | Moderate malodor |
6 | Slightly strong malodor |
7 | Moderate intense malodor |
8 | Intense malodor |
9 | Very strong malodor |
10 | Extremely strong malodor |
TABLE 3
TABLE 3 Table 3
Comparative example 1-1 is an average value of odor of an armpit after the composition of comparative example 1 was applied to one armpit, in a group of subjects having the composition of comparative example 1 applied to the other armpit.
Comparative examples 1 to 2 are average values of odor of armpits after the composition of comparative example 1 was applied to the armpits in the group of subjects having the composition of example 2 applied to one armpit and the composition of comparative example 1 applied to the other armpit.
Comparative examples 1 to 3 are average values of odor of armpits after the composition of comparative example 1 was applied to one armpit, in the group of subjects having the composition of comparative example 1 applied to the other armpit.
Comparative examples 2 to 4 are average values of odor of armpits after the composition of comparative example 2 was applied to one armpit, and the composition of comparative example 2 was applied to the other armpit, among the groups of subjects having the composition of example 4 applied to the other armpit.
Comparative examples 2 to 5 are average values of odor of armpits after the composition of comparative example 2 was applied to one armpit, and the composition of comparative example 2 was applied to the other armpit, among the groups of subjects having the composition of example 5 applied to the other armpit.
Results: the composition for preventing bromhidrosis of the present invention can be confirmed to exert an excellent bromhidrosis preventing effect. In addition, in the same human sensory evaluation test as in test example 1, the same effect of preventing bromhidrosis was confirmed by performing the test using a cream containing 0.2 mass% of miconazole nitrate.
Test example 2: production inhibition effect of malodorous substances in miconazole nitrate
The odor components were collected from the underarm of the subjects participating in test example 1 (subjects who applied the compositions of example 2 and comparative example 1 to the respective armpits) before application, 24 hours after the final application, and 48 hours after the final application, and the odor components shown below were quantified. The malodorous component is generally 5 components, namely 3-hydroxy-3-methylhexanoic acid, 3-methyl-2-hexenoic acid, isovaleric acid, 3-methyl-3-mercaptohexane-1-ol, and 3-mercapto-1-hexanol, which are considered to be the cause of bromhidrosis. The collection of gases produced from human skin uses the PFS (passive flux sampler ) method. By wearing PFS on the skin surface, volatile components generated from the skin surface diffuse within PFS and are trapped by the adsorbent incorporated into the PFS. As the adsorbent for this test, monoTrap (registered trademark) DSC18 (0.778 cm 2) manufactured by industrial corporation was used. The wearing time of the PFS was set to 2 hours, and the PFS was stored frozen or refrigerated after collection. Odor components were extracted from the adsorbent material inside the PFS, and the collected components were analyzed by a Gas Chromatography Mass Spectrometer (GCMS). The average value (+/-SE) of 26 pieces of PFS that can be recovered is shown in FIGS. 6 to 10.
Results: by compounding miconazole nitrate as an azole antifungal agent, the production of various odor components can be suppressed. The results also relate to the results of test example 1, and they revealed that azole antifungal agents such as miconazole nitrate widely inhibit the production of malodorous components and exert excellent bromhidrosis preventing effects.
Test example 3: effect of astringent ingredients on the solubility of miconazole nitrate
The composition for preventing bromhidrosis (composition for suppressing the generation of an odorous substance) was prepared so that the total amount of the mixture described in tables 4-1 and 4-2 was 100% by mass.
Specifically, miconazole nitrate was dissolved in Propylene Glycol (PG) and ethanol, and heated to about 80 ℃ as needed, and stirred with a stirrer, confirming complete dissolution of miconazole nitrate. Separately from this, a water-soluble substance containing various components that can be used as an astringent was heated to about 80 ℃ as needed, and after confirming complete dissolution of the above components, the mixture was added to a miconazole nitrate-dissolved substance. Further, purified water was added while stirring to prepare an anti-bromhidrosis composition (an odor substance generation-inhibiting composition) for each formulation. After transferring the composition for preventing bromhidrosis (composition for inhibiting the generation of malodor substance) used in the evaluation test into a sealed container made of glass, it was confirmed by visual observation that all components were completely dissolved, and then the sealed container was left for a predetermined period of time at room temperature and at 0 ℃.
The presence or absence of miconazole nitrate precipitation was determined according to the following criteria.
And (2) the following steps: needle-like crystals were not precipitated.
X: needle-like crystals precipitated.
The amounts of the respective components in the table are expressed as mass% based on the total mass of the composition for preventing bromhidrosis (composition for inhibiting the generation of malodor substances).
[ Table 4-1]
TABLE 4-2
Prescription 8 | Prescription 9 | Prescription 10 | |
Miconazole nitrate | 0.05 | 0.05 | 0.05 |
Propylene glycol | 3 | 3 | 3 |
Ethanol | 20 | 20 | 20 |
Succinic acid | 0.3 | ||
Tartaric acid | 0.3 | ||
Malic acid | 0.3 | ||
Water and its preparation method | 76.65 | 76.65 | 76.65 |
Totalizing | 100 | 100 | 100 |
Stored at room temperature for 1 week | ○ | ○ | ○ |
Preserving at 0deg.C for 1 week | ○ | ○ | ○ |
Results: by blending aluminum chlorohydrate, citric acid, lactic acid, tannic acid, zinc p-phenolsulfonate, alum, succinic acid, tartaric acid, and malic acid, which can be used as an astringent, the precipitation of miconazole nitrate can be suppressed. That is, it was found that miconazole nitrate formulations could be stably preserved by compounding aluminum chlorohydrate, citric acid, lactic acid, tannic acid, zinc p-phenolsulfonate, alum, succinic acid, tartaric acid, and malic acid.
Test example 4: effect of antioxidant ingredient on the solubility of miconazole nitrate
An anti-bromhidrosis composition (malodor-reducing composition) was prepared so that the total amount of the mixture was 100% by mass as shown in Table 5.
Specifically, miconazole nitrate was dissolved in Propylene Glycol (PG) and ethanol, and heated to about 80 ℃ as needed, and stirred with a stirrer, so that it was confirmed that miconazole nitrate was completely dissolved. Separately from this, a water-soluble substance containing various components that can be used as an antioxidant was heated to about 80 ℃ as needed, and after confirming complete dissolution of the above components, the mixture was added to a miconazole nitrate-dissolved substance. In addition, an antioxidant which is not dissolved in water was dissolved in PG and ethanol. Further, purified water was added while stirring to prepare an anti-bromhidrosis composition (an odor substance generation-inhibiting composition) for each formulation. After transferring the composition for preventing bromhidrosis (composition for inhibiting the generation of malodor substance) used in the evaluation test to a sealed container made of glass, it was visually confirmed that all components were completely dissolved, and then the sealed container was left for a predetermined period of time at room temperature and 0 ℃.
The presence or absence of miconazole nitrate precipitation was determined according to the following criteria.
And (2) the following steps: needle-like crystals were not precipitated.
X: needle-like crystals precipitated.
The amounts of the respective components in the table are expressed as mass% based on the total mass of the composition for preventing bromhidrosis (composition for inhibiting the generation of malodor substances).
TABLE 5
Results: by compounding dl-alpha-tocopherol, d-delta-tocopherol, tocopheryl phosphate Na, tea extract, retinol palmitate, 3-O-ethyl ascorbic acid, propyl gallate and linoleic acid, which can be used as antioxidants, precipitation of miconazole nitrate can be suppressed. That is, it was found that the miconazole nitrate formulation could be stably preserved by compounding dl-alpha-tocopherol, d-delta-tocopherol, na tocopheryl phosphate, tea extract, retinol palmitate, 3-O-ethyl ascorbic acid, propyl gallate, linoleic acid, and miconazole nitrate.
Test example 5: effect of astringent ingredients on solubility of ketoconazole
An anti-bromhidrosis composition (malodor-reducing composition) was prepared so that the total amount of the mixture was 100% by mass as shown in Table 6.
Specifically, ketoconazole was dissolved in Propylene Glycol (PG) and ethanol, and heated to about 80 ℃ as needed, and stirred with a stirrer, confirming complete dissolution of ketoconazole. Separately from this, a water-soluble substance of each component that can be used as an astringent was heated to about 80 ℃ as needed, and after confirming that each component was completely dissolved, it was added to a ketoconazole-dissolved substance. Further, purified water was added while stirring to prepare an anti-bromhidrosis composition (an odor substance generation-inhibiting composition) for each formulation. After the composition for preventing bromhidrosis (composition for inhibiting the generation of an odor substance) used in the evaluation test was transferred to a glass-made sealed container, it was visually confirmed that all components were completely dissolved, and the sealed container was left for a predetermined period of time at room temperature and 0 ℃.
The presence or absence of ketoconazole deposition was determined according to the following criteria.
And (2) the following steps: needle-like crystals were not precipitated.
X: needle-like crystals precipitated.
The amounts of the respective components in the table are expressed as mass% based on the total mass of the composition for preventing bromhidrosis (composition for inhibiting the generation of malodor substances).
TABLE 6
TABLE 6
Control | Prescription 19 | Prescription 20 | Prescription 21 | |
Ketoconazole | 0.05 | 0.05 | 0.05 | 0.05 |
Propylene glycol | 3 | 3 | 3 | 3 |
Ethanol | 20 | 20 | 20 | 20 |
Basic aluminum chloride | 0.3 | |||
Citric acid | 0.3 | |||
P-phenol zinc sulfonate | 0.3 | |||
Water and its preparation method | 76.95 | 76.65 | 76.65 | 76.65 |
Totalizing | 100 | 100 | 100 | 100 |
Stored at room temperature for 1 week | × | ○ | ○ | ○ |
Preserving at 0deg.C for 1 week | × | ○ | ○ | ○ |
Results: by compounding aluminum chlorohydrate, citric acid, and zinc p-phenolsulfonate, which can be used as astringents, the precipitation of ketoconazole can be suppressed. That is, it was found that the ketoconazole formulations can be stably preserved by compounding aluminum chlorohydrate, citric acid, and zinc p-phenolsulfonate.
Formulation example 1: liquid formulation
Based on the prescription shown in table 7 below, an anti-bromhidrosis composition (an odor substance generation suppressing composition) was prepared. The values in each table refer to mass%.
Miconazole nitrate, isopropyl methylphenol, zinc oxide (available in the sub-scale)), hydroxyapatite, menthol, isopropyl myristate, methyl phenyl polysiloxane, (acrylate/polydimethylsiloxane) copolymer, and acrylate copolymer were dissolved in ethanol. Further, 1, 3-butanediol, hydrophobized hydroxypropyl methylcellulose, hydroxypropyl- β -cyclodextrin, edta.2na, zinc p-phenolsulfonate, and aluminum chlorohydrate were dissolved in purified water. Further, the two components were mixed to prepare a liquid formulation for each prescription.
TABLE 7
TABLE 7
Prescription 22 | Prescription 23 | Prescription 24 | Prescription 25 | |
Miconazole nitrate | 0.05 | 0.05 | 0.05 | 0.05 |
Isopropyl methylphenol | 0.05 | |||
Zinc oxide (acidized subtype) (zinc oxide (subtype)) | 0.5 | |||
Hydroxyapatite | 0.5 | |||
Menthol | 0.3 | 0.3 | 0.3 | 0.3 |
Myristic acid isopropyl ester | 0.1 | |||
Methyl phenyl polysiloxane | 0.1 | |||
Ethanol | 50 | 40 | 40 | 40 |
(Acrylate/polydimethylsiloxane) copolymers | 0.2 | |||
Acrylic ester copolymer | 0.2 | |||
1, 3-Butanediol | 0.1 | |||
Hydrophobized hydroxypropyl methylcellulose | 0.05 | 0.05 | 0.05 | 0.05 |
Hydroxypropyl-beta-cyclodextrin | 1 | 1 | 1 | 1 |
EDTA·2Na | 0.05 | 0.05 | 0.05 | 0.05 |
Purified water | 46.85 | 53.55 | 57.25 | 52.8 |
P-phenol zinc sulfonate | 1 | 1 | ||
Basic aluminum chloride | 5 | 5 | ||
Totalizing | 100 | 100 | 100 | 100 |
Each preparation, miconazole nitrate, does not precipitate, can be stably stored for 1 year at room temperature, and can be stably stored for half a year at a humidity of 75% at 40 ℃.
Claims (26)
1. A composition for preventing bromhidrosis, which comprises at least 1 azole component selected from the group consisting of azoles and its salts,
The azole component is contained in an amount of 0.01 to 0.2% by mass based on the composition for preventing bromhidrosis.
2. The composition for preventing bromhidrosis according to claim 1, wherein the azole is miconazole or ketoconazole.
3. The composition for preventing bromhidrosis according to claim 1 or 2, further comprising an astringent.
4. The composition for preventing bromhidrosis according to claim 3, wherein the astringent is at least 1 astringent selected from the group consisting of zinc p-phenolsulfonate, aluminum chlorohydrate, citric acid, lactic acid, tannic acid, alum, succinic acid, tartaric acid and malic acid.
5. The composition for preventing bromhidrosis according to claim 3, wherein precipitation of the azole component is suppressed.
6. The composition for preventing bromhidrosis according to claim 1 or 2, further comprising an antioxidant.
7. The composition for preventing bromhidrosis according to claim 6, wherein the antioxidant is at least 1 antioxidant selected from the group consisting of tocopherol and derivatives thereof, tea extract, vitamin a and derivatives thereof, vitamin C and derivatives thereof, propyl gallate and linoleic acid.
8. The composition for preventing bromhidrosis according to claim 6, wherein precipitation of the azole component is suppressed.
9. The composition for preventing bromhidrosis according to claim 1 or 2, which is in a dosage form selected from the group consisting of cream, liquid, spray, stick and ball.
10. A method for preventing bromhidrosis, applying the bromhidrosis preventing composition according to claim 1 or 2 to the axilla.
11. A composition for inhibiting the generation of an odorous substance, which comprises at least 1 azole component selected from the group consisting of azoles and salts thereof,
The content of the azole component is 0.01 to 0.2% by mass based on the composition for inhibiting the generation of an odorous substance.
12. The composition for inhibiting the production of an odorous substance according to claim 11, wherein the azole is miconazole or ketoconazole.
13. The composition for inhibiting the production of an odorant according to claim 11 or 12, wherein the odorant is at least 1 odorant selected from the group consisting of 3-hydroxy-3-methylhexanoic acid, 3-methyl-2-hexenoic acid, isovaleric acid, 3-methyl-3-mercaptohexane-1-ol and 3-mercapto-1-hexanol.
14. The composition for inhibiting the production of an odorous substance according to claim 11 or 12, further comprising an astringent.
15. The composition for inhibiting the production of an malodorous substance according to claim 14, wherein the astringent is at least 1 astringent selected from the group consisting of zinc p-phenolsulfonate, aluminum chlorohydrate, citric acid, lactic acid, tannic acid, alum, succinic acid, tartaric acid, and malic acid.
16. The composition for inhibiting the production of an odorous substance according to claim 14, wherein the precipitation of the azole component is inhibited.
17. The composition for inhibiting the production of an odorous substance according to claim 11 or 12, further comprising an antioxidant.
18. The composition for inhibiting the production of an odorous substance according to claim 17, wherein the antioxidant is at least 1 antioxidant selected from the group consisting of tocopherol and its derivatives, tea extract, vitamin a and its derivatives, vitamin C and its derivatives, propyl gallate and linoleic acid.
19. The composition for inhibiting the production of an odorous substance according to claim 17, wherein the precipitation of the azole component is inhibited.
20. The composition for inhibiting the production of an odorous substance according to claim 11 or 12, wherein the dosage form of the composition for inhibiting the production of an odorous substance is a dosage form selected from the group consisting of cream, liquid, spray, stick and roll-on.
21. A method of suppressing the production of an odorous substance, which comprises applying the odorous substance production-suppressing composition according to claim 11 or 12 to the axilla.
22. A method of inhibiting precipitation of an azole component comprising: at least 1 selected from zinc p-phenolsulfonate, aluminum chlorohydrate, citric acid, lactic acid, tannic acid, alum, succinic acid, tartaric acid and malic acid is mixed with a composition for external use containing at least 1 selected from the group consisting of oxazoles and salts thereof.
23. A method of inhibiting precipitation of an azole component comprising: at least 1 selected from tocopherol and its derivatives, tea extract, vitamin A and its derivatives, vitamin C and its derivatives, propyl gallate and linoleic acid are mixed with a topical composition containing at least 1 selected from oxazole and its salts.
24. The method of claim 22 or 23, wherein the azole is miconazole or ketoconazole.
25. The method of claim 22 or 23, wherein the topical composition is in the form of a liquid formulation.
26. The method according to claim 22 or 23, wherein the composition for external use is at least 1 selected from the group consisting of an composition for preventing bromhidrosis and an composition for inhibiting the production of an odorous substance.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163245537P | 2021-09-17 | 2021-09-17 | |
US63/245,537 | 2021-09-17 | ||
PCT/JP2022/034773 WO2023042911A1 (en) | 2021-09-17 | 2022-09-16 | Anti-armpit-odor composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117940109A true CN117940109A (en) | 2024-04-26 |
Family
ID=85602969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202280062267.6A Pending CN117940109A (en) | 2021-09-17 | 2022-09-16 | Composition for preventing bromhidrosis |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN117940109A (en) |
WO (1) | WO2023042911A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3886890B2 (en) * | 2002-12-09 | 2007-02-28 | 株式会社マンダム | Odor prevention cosmetics |
JP2012219046A (en) * | 2011-04-06 | 2012-11-12 | Lion Corp | Deodorant composition for external application to skin |
CN102688258A (en) * | 2012-06-16 | 2012-09-26 | 李泽红 | Medicine for external use for treating psoriasis, leucoderma, fungus infection and bromhidrosis |
JP6474963B2 (en) * | 2014-03-04 | 2019-02-27 | 持田製薬株式会社 | Cleaning composition |
-
2022
- 2022-09-16 WO PCT/JP2022/034773 patent/WO2023042911A1/en active Application Filing
- 2022-09-16 CN CN202280062267.6A patent/CN117940109A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2023042911A1 (en) | 2023-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090093440A1 (en) | Fragranced Therapeutic Delivery System | |
US8303941B2 (en) | Chelated mineral water | |
JP2000247853A (en) | Use of 3-substituted stilbene derivative as deodorizing active agent in cosmetic composition | |
KR20060052991A (en) | Stabilized antiperspirant compositions containing soy products | |
PL189774B1 (en) | Cosmetic composition containing antiperspirant or deodorising agent and moistening cream | |
JP3908244B2 (en) | Male deodorant deodorant | |
EP3946223B1 (en) | Antiperspirant and deodorant compositions | |
ES2924128T3 (en) | deodorant products | |
KR102463133B1 (en) | Cosmetic Composition Containing High-Content of Urea | |
WO2023094517A1 (en) | A topical composition | |
EP3226827B1 (en) | Aluminium-free antiperspirant/deodorant compositions and method of preparing the same | |
CN117940109A (en) | Composition for preventing bromhidrosis | |
JP2002370958A (en) | Liquid cosmetic material | |
JP5275637B2 (en) | Topical skin preparation | |
JP2002531474A (en) | Deodorant cosmetic composition | |
KR20240069718A (en) | Composition for preventing odor | |
EP2353579B1 (en) | Deodorant composition | |
JP5025535B2 (en) | Antibacterial agent composition and deodorant composition | |
JPH07215832A (en) | Skin external preparation | |
JP7361488B2 (en) | Solubilized composition for water-soluble compounds and oil-soluble compounds | |
WO2020216696A1 (en) | Deodorant or antiperspirant composition containing a calcium or lactate donor | |
JP2002161018A (en) | Cosmetic | |
JP2008111000A (en) | Antibacterial composition and deodorant agent | |
WO2022241143A1 (en) | Personal care compositions | |
JP6632210B2 (en) | Masking composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |